Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Atherosclerosis

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    March 2017
  1. LAMACCHIA O, Fontana A, Pacilli A, Copetti M, et al
    On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus.
    Atherosclerosis. 2017;260:20-26.
    PubMed     Text format     Abstract available


    February 2017
  2. FELDMAN DI, Valero-Elizondo J, Salami JA, Rana JS, et al
    Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS).
    Atherosclerosis. 2017;258:79-83.
    PubMed     Text format     Abstract available


    January 2017
  3. MAILE LA, Busby WH, Xi G, Gollahan KP, et al
    An anti-alphaVbeta3 antibody inhibits coronary artery atherosclerosis in diabetic pigs.
    Atherosclerosis. 2017;258:40-50.
    PubMed     Text format     Abstract available


    December 2016
  4. LEE DH, Chun EJ, Hur JH, Min SH, et al
    Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes.
    Atherosclerosis. 2016;257:47-54.
    PubMed     Text format     Abstract available


  5. CHEN J, Zhang J, Yang J, Xu L, et al
    Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
    Atherosclerosis. 2016;257:152-163.
    PubMed     Text format     Abstract available


  6. SCHOFIELD JD, Steiner R, Liu Y, Hobkirk J, et al
    Sphingolipids and deoxysphingolipids in diabetes.
    Atherosclerosis. 2016;255:4.
    PubMed     Text format    


  7. BANERJEE P, Appleton M, Bowron A, Bartlett K, et al
    Ceramides in diabetes.
    Atherosclerosis. 2016;255:1-2.
    PubMed     Text format    


    November 2016
  8. LANGSTED A, Freiberg JJ, Nordestgaard BG
    Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004-2014.
    Atherosclerosis. 2016;257:9-15.
    PubMed     Text format     Abstract available


  9. SCICALI R, Giral P, Gallo A, Di Pino A, et al
    HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
    Atherosclerosis. 2016;255:102-108.
    PubMed     Text format     Abstract available


  10. NAKANISHI R, Ceponiene I, Osawa K, Luo Y, et al
    Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study.
    Atherosclerosis. 2016;255:73-79.
    PubMed     Text format     Abstract available


    September 2016
  11. BERK KA, Vongpromek R, Jiang M, Schneider WJ, et al
    Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.
    Atherosclerosis. 2016;254:67-72.
    PubMed     Text format     Abstract available


  12. AFARIDEH M, Aryan Z, Ghajar A, Noshad S, et al
    Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes.
    Atherosclerosis. 2016;254:42-51.
    PubMed     Text format     Abstract available


    August 2016
  13. KIANOUSH S, Blaha MJ
    Early interventions for optimal control of prediabetes and diabetes: Critical to prevent cardiovascular disease?
    Atherosclerosis. 2016 Aug 28. pii: S0021-9150(16)31307.
    PubMed     Text format    


  14. HEFFERNAN KS
    Carotid artery stiffness and cognitive function in adults with and without type 2 diabetes: Extracranial contribution to an intracranial problem?
    Atherosclerosis. 2016 Aug 27. pii: S0021-9150(16)31297.
    PubMed     Text format    


  15. FIORENTINO TV, Sesti F, Andreozzi F, Pedace E, et al
    One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden.
    Atherosclerosis. 2016;253:61-69.
    PubMed     Text format     Abstract available


  16. IKEDA N, Hara H, Hiroi Y, Nakamura M, et al
    Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
    Atherosclerosis. 2016;253:1-6.
    PubMed     Text format     Abstract available


    July 2016
  17. GEIJSELAERS SL, Sep SJ, Schram MT, van Boxtel MP, et al
    Carotid stiffness is associated with impairment of cognitive performance in individuals with and without type 2 diabetes. The Maastricht Study.
    Atherosclerosis. 2016 Jul 22. pii: S0021-9150(16)31213.
    PubMed     Text format     Abstract available


  18. WYCHERLEY TP, Thompson CH, Buckley JD, Luscombe-Marsh ND, et al
    Long-term effects of weight loss with a very-low carbohydrate, low saturated fat diet on flow mediated dilatation in patients with type 2 diabetes: A randomised controlled trial.
    Atherosclerosis. 2016;252:28-31.
    PubMed     Text format     Abstract available


  19. THEN C, Rottenkolber M, Lechner A, Meisinger C, et al
    Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study.
    Atherosclerosis. 2016;252:88-96.
    PubMed     Text format     Abstract available


    June 2016
  20. BEN NASR M, Fiorina P
    CXCR4 antagonism overcomes diabetic stem cell mobilopathy.
    Atherosclerosis. 2016 Jun 23. pii: S0021-9150(16)30268.
    PubMed     Text format    


  21. BORRADAILE N, Le Goff W
    Lipidomic approach provides new clues toward solving the mystery of accelerated atherosclerosis in diabetes.
    Atherosclerosis. 2016 Jun 11. pii: S0021-9150(16)30247.
    PubMed     Text format    


    May 2016
  22. CAPPELLARI R, D'Anna M, Avogaro A, Fadini GP, et al
    Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry.
    Atherosclerosis. 2016 May 20. pii: S0021-9150(16)30205.
    PubMed     Text format     Abstract available


  23. NARDIN M, Verdoia M, Schaffer A, Barbieri L, et al
    Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.
    Atherosclerosis. 2016;250:114-121.
    PubMed     Text format     Abstract available


  24. MENEGAUT L, Masson D, Abello N, Denimal D, et al
    Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
    Atherosclerosis. 2016 May 4. pii: S0021-9150(16)30164.
    PubMed     Text format     Abstract available


  25. KIEC-WILK B, Matejko B, Razny U, Stankiewicz M, et al
    Hypoglycemic episodes are associated with inflammatory status in patients with type 1 diabetes mellitus.
    Atherosclerosis. 2016 May 3. pii: S0021-9150(16)30162.
    PubMed     Text format     Abstract available


  26. ARONER SA, St-Jules DE, Mukamal KJ, Katz R, et al
    Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2016;248:224-9.
    PubMed     Text format     Abstract available


  27. KIM SA, Park SH, Jo SH, Park KH, et al
    Alterations of carotid arterial mechanics preceding the wall thickening in patients with hypertension.
    Atherosclerosis. 2016;248:84-90.
    PubMed     Text format     Abstract available


  28. PAN L, Yang Z, Wu Y, Yin RX, et al
    The prevalence, awareness, treatment and control of dyslipidemia among adults in China.
    Atherosclerosis. 2016;248:2-9.
    PubMed     Text format     Abstract available


    April 2016
  29. ORTEGA MORENO L, Lamacchia O, Fontana A, Copetti M, et al
    The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: Evidence of synergism with abdominal adiposity.
    Atherosclerosis. 2016;250:23-29.
    PubMed     Text format     Abstract available


  30. LANDMAN GW, Kleefstra N, Groenier KH, Bakker SJ, et al
    Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Atherosclerosis. 2016;250:46-51.
    PubMed     Text format     Abstract available


  31. WILLIAMS KJ, Wu X
    Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward.
    Atherosclerosis. 2016;247:225-82.
    PubMed     Text format     Abstract available


    March 2016
  32. CAMEJO G
    Selective PPAR modulators (SPPARs) may fill the need for treatment of the atherogenic dyslipidemia of insulin resistance and type 2 diabetes: Can they reduce the associated cardiac risk?
    Atherosclerosis. 2016 Mar 22. pii: S0021-9150(16)30101.
    PubMed     Text format    


    February 2016
  33. AMOR AJ, Catalan M, Perez A, Herreras Z, et al
    Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis.
    Atherosclerosis. 2016;247:161-169.
    PubMed     Text format     Abstract available


  34. FETTERMAN JL, Holbrook M, Flint N, Feng B, et al
    Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling.
    Atherosclerosis. 2016;247:207-217.
    PubMed     Text format     Abstract available


  35. BARKAS F, Elisaf M, Liberopoulos E, Liontos A, et al
    High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome.
    Atherosclerosis. 2016;247:58-63.
    PubMed     Text format     Abstract available


    January 2016
  36. EGUCHI K, Hoshide S, Miyashita H, Nagasaka S, et al
    Why the radial augmentation index is low in patients with diabetes: The J-HOP study.
    Atherosclerosis. 2016;246:338-343.
    PubMed     Text format     Abstract available


  37. TSUNODA F, Asztalos IB, Horvath KV, Steiner G, et al
    Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial.
    Atherosclerosis. 2016;247:35-39.
    PubMed     Text format     Abstract available


  38. LEE YH, Shin MH, Choi JS, Rhee JA, et al
    HbA1c is significantly associated with arterial stiffness but not with carotid atherosclerosis in a community-based population without type 2 diabetes: The Dong-gu study.
    Atherosclerosis. 2016;247:1-6.
    PubMed     Text format     Abstract available


  39. DENIMAL D, Nguyen A, Pais de Barros JP, Bouillet B, et al
    Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome.
    Atherosclerosis. 2016;246:106-114.
    PubMed     Text format     Abstract available


    December 2015
  40. ORTEGA MORENO L, Lamacchia O, Salvemini L, De Bonis C, et al
    The paradoxical association of adiponectin with mortality rate in patients with type 2 diabetes: evidence of synergism with kidney function.
    Atherosclerosis. 2015;245:222-227.
    PubMed     Text format     Abstract available


  41. RHEE EJ, Kim JH, Park HJ, Park SE, et al
    Increased risk for development of coronary artery calcification in insulin-resistant subjects who developed diabetes: 4-year longitudinal study.
    Atherosclerosis. 2015;245:132-138.
    PubMed     Text format     Abstract available


    November 2015
  42. BOSSI F, Bernardi S, De Nardo D, Bramante A, et al
    Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro.
    Atherosclerosis. 2015;244:121-130.
    PubMed     Text format     Abstract available


  43. CHEN X, Bakillah A, Zhou L, Pan X, et al
    Nitrated apolipoprotein AI/apolipoprotein AI ratio is increased in diabetic patients with coronary artery disease.
    Atherosclerosis. 2015;245:12-21.
    PubMed     Text format     Abstract available


    October 2015
  44. BASU A, Jenkins AJ, Zhang Y, Stoner JA, et al
    Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Atherosclerosis. 2015;244:93-100.
    PubMed     Text format     Abstract available


  45. PURI R, Nissen SE, Menon V, Shao M, et al
    Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
    Atherosclerosis. 2015;243:553-559.
    PubMed     Text format     Abstract available


  46. LU J, Xiang G, Liu M, Mei W, et al
    Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Atherosclerosis. 2015;243:438-448.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: